These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25366905)

  • 1. Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma.
    Syed N; Barbhuiya MA; Pinto SM; Nirujogi RS; Renuse S; Datta KK; Khan AA; Srikumar K; Prasad TS; Kumar MV; Kumar RV; Chatterjee A; Pandey A; Gowda H
    Proteomics; 2015 Jan; 15(2-3):374-82. PubMed ID: 25366905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
    Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
    Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
    Shin WS; Hong Y; Lee HW; Lee ST
    Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Under-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.
    Li X; Zheng S; Liu Q; Liu T; Liang M; Gao X; Lu M; Sheyhidin I; Lu X
    Mol Carcinog; 2015 Sep; 54(9):779-88. PubMed ID: 24668792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP1B contributes to calreticulin-induced metastatic phenotypes in esophageal squamous cell carcinoma.
    Wang XM; Shang L; Zhang Y; Hao JJ; Shi F; Luo W; Zhang TT; Wang BS; Yang Y; Liu ZH; Zhan QM; Wang MR
    Mol Cancer Res; 2013 Sep; 11(9):986-94. PubMed ID: 23814025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling.
    Liu X; Yan Y; Ma W; Wu S
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Src tyrosine kinase in esophageal carcinoma cells in different regulatory environments and corresponding occurrence mechanism.
    Yu ZS; Song XH; Gan HM; Geng DZ; Yang J
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
    Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
    Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Protein Tyrosine Phosphatase Receptor J Expression Predicts an Aggressive Clinical Course in Patients with Esophageal Squamous Cell Carcinoma.
    Qiao D; Li M; Pu J; Wang W; Zhu W; Liu H
    Pathol Oncol Res; 2016 Jul; 22(3):541-7. PubMed ID: 26694178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
    Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
    Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.
    Cheng R; Zhu S; Guo S; Min L; Xing J; Guo Q; Li P; Zhang S
    Oncol Rep; 2018 Jun; 39(6):2575-2583. PubMed ID: 29620226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.